Volume 21, Issue 3 (6-2018)                   J Arak Uni Med Sci 2018, 21(3): 104-113 | Back to browse issues page

XML Persian Abstract Print

1- Department of Ophthalmology, Eye Research Center, Rassoul Akram Hospital, Iran University of Medical Sciences, Tehran, Iran. , naveednil@yahoo.com
2- Department of Ophthalmology, Eye Research Center, Rassoul Akram Hospital, Iran University of Medical Sciences, Tehran, Iran.
3- Department of Ophthalmology, Eye Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
4- Department of Ophthalmology, Eye Research Center, Rassoul Akram Hospital, Iran University of Medical Sciences, Tehran, Iran. Student Research Committee, Iran University of Medical Sciences, Tehran, Iran.
Abstract:   (4293 Views)
Background and Aim: The aim of this study was to evaluate the success rate and complications of Ahmed Glaucoma Valve (AGV) insertion during a follow up of at least 5 years.
Materials and Methods: In this retrospective case series study, patients with 5 years of follow up after AGV insertion were enrolled. Success was defined as intraocular pressure (IOP) < 21 mm Hg (criterion A) and IOP < 16 mm Hg (criterion B), with at least 20% reduction in IOP, either with no medication (complete success) or with no more than preoperative medication (qualified success). Cumulative success was defined as sum of qualified and complete success.
Findings: This study included 40 eyes of 40 patients with mean age of 40.63± 22.91years, (range 1 to 88). Cumulative survival success rates were 90%, 73% at 1 and 5 years after surgery according to criterion A and 42%, 25% based on criterion B with the median survival time of 60 months and 22.36 months, respectively. Complications were observed in 4 eyes of 4 patients (10%) and included wound dehiscence, choroidal detachment, encapsulated bleb and lid retraction. There were not any early complications such as hypotonia or hyphema.
Conclusion: The present study was one of the largest series that reported the long-term outcome of AGV implantation in Asian patients with refractory glaucoma, and showed the wide difference of success rate between criterion A and B.

Full-Text [PDF 2171 kb]   (6962 Downloads)    
Type of Study: Original Atricle | Subject: Surgery
Received: 2018/02/12 | Accepted: 2018/05/9

1. Stevens GA, White RA, Flaxman SR, et al. Global prevalence of vision impairment and blindness: magnitude and temporal trends, 1990-2010. Ophthalmology. 2013; 120(12):2377-84.
2. Desai MA, Gedde SJ, Feuer WJ, Shi W, Chen PP, Parrish RK, 2nd. Practice preferences for glaucoma surgery: a survey of the american glaucoma society in 2008. Ophthalmic Ophthalmic Surg Lasers Imaging. 2011; 42(3).
3. Joshi AB, Parrish RK, 2nd, Feuer WF. 2002 survey of the American Glaucoma Society: practice preferences for glaucoma surgery and antifibrotic use. J glaucoma. 2005; 14(2):172-4.
4. Gedde SJ, Singh K, Schiffman JC, Feuer WJ, Tube Versus Trabeculectomy Study Group. The Tube Versus Trabeculectomy Study: interpretation of results and application to clinical practice. Curr Opin Ophthalmol. 2012; 23(2):118-26.
5. Khan AO, Almobarak FA. Comparison of polypropylene and silicone Ahmed valve survival 2 years following implantation in the first 2 years of life. Br J Ophthalmol. 2009; 93(6):791-4.
6. Heuer DK, Lloyd MA, Abrams DA, et al. Which is better? One or two? A randomized clinical trial of single plate versus double plate Molteno implantation for glaucoma in aphakia and pseudophakia. Ophthalmology. 1992; 99(10):1512-9.
7. Siegner SW, Netland PA, Urban RC, et al. Clinical experience with the Baerveldt glaucoma drainage implant. Ophthalmology. 1995; 102(9):1298-307.
8. Coleman AL, Hill R, Wilson MR, et al. Initial clinical experience with the Ahmed Glaucoma Valve implant. Am J Ophthalmol. 1995; 120(1):23-31.
9. Barton K, Feuer WJ, Budenz DL, et al. Three-year treatment outcomes in the Ahmed Baerveldt comparison study. Ophthalmology. 2014; 121(8):1547-57 e1.
10. Budenz DL, Barton K, Gedde SJ, et al. Five-year treatment outcomes in the Ahmed Baerveldt comparison study. Ophthalmology. 2015; 122(2):308-16.
11. Abe RY, Tavares CM, Schimiti RB, Vasconcellos JP, Costa VP. Ahmed Glaucoma Valve Implantation for Refractory Glaucoma in a Tertiary Hospital in Brazil. Journal of ophthalmology. 2015;2015: 850785.
12. Muldoon WE, Ripple PH, Wilder HC. Platinum implant in glaucoma surgery. Arch Ophthalmol. 1951; 45(6):666-72.
13. Ellis RA. Reduction of intraocular pressure using plasticsin surgery. Am J Ophthalmol. 1960; 50:733-42.
14. Molteno AC. New implant for drainage in glaucoma: clinical trial. Br J Ophthalmol 1969; 53(9):606-15.
15. Molteno AC. The optimal design of drainage implants for glaucoma. Trans Ophthalmol Soc N Z. 1981; 33:39-41.
16. Hong CH, Arosemena A, Zurakowski D, Ayyala RS. Glaucoma drainage devices: a systematic literature review and current controversies. Surv Ophthalmol. 2005; 50(1):48-60.
17. Smith SL, Starita RJ, Fellman RL, Lynn JR. Early clinical experience with the Baerveldt 350-mm2 glaucoma implant and associated extraocular muscleimbalance. Ophthalmology. 1993; 100(6): 914-8.
18. Jaacob-Labarre JT, McKinnon SJ, Tanji T, LaFleur P, Duzman E. Biocompatibility response to modified Baerveldt glaucoma drains. J Biomed Mater Res (Appl Biomater) 1998; 43: 99–107.
19. Ayyala RS, Harman LE, Michelini-Norris AF, et al. Comparison of different biomaterials for the glaucoma drainage devices. Arch Ophthalmol. 1999; 117(2):233-6.
20. Ayyala RS, Michelini-Norris AF, Flores A, Haller E, Margo CE. Comparison of different biomaterials for glaucoma drainage devices. Part 2. Arch Ophthalmol. 2000; 118(8):1081-4.
21. Wilson MR, Mendis U, Smith SD, Paliwal A. Ahmed glaucoma valve implant vs trabeculectomy in the surgical treatment of glaucoma: a randomized clinical trial. Am J Ophthalmol. 2000; 130(3):267-73.
22. Katz LJ, Spaeth GL: Surgical management of the secondary glaucomas. Part I. Ophthalmic Surg. 1987; 18(11):826-34.
23. Souza C, Tran DH, Loman J, Law SK, Coleman AL, Caprioli J. Long-term outcomes of Ahmed glaucoma valve implantation in refractory glaucomas. Amj Ophthalmol 2007; 144(6):893-900.
24. Zarei R, Amini H, Daneshvar R, et al. Long-term Outcomes of Ahmed Glaucoma Valve Implantation in Refractory Glaucoma at Farabi Eye Hospital, Tehran, Iran. Middle East Afr J Ophthalmol. 2016; 23(1):104-9.

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.